Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation

Journal of Medical Investigation

Volumn 51, Issue 1-2, 2004, Pages 76-83

  Sasaki, Katsuya ^a   Miyake, Hidenori ^a   Kinoshita, Takafumi ^a   Ikeyama, Shizuo ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

FK506; Ischemia reperfusion injury; Non heart beating donor; OKY046; Orthotopic liver transplantation

Indexed keywords

CYTOKINE; DRUG VEHICLE; LIVER ENZYME; OZAGREL; TACROLIMUS; THROMBOXANE SYNTHASE INHIBITOR; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHACRYLIC ACID DERIVATIVE; THROMBOXANE SYNTHASE;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADAVER DONOR; DRUG EFFECT; DRUG MECHANISM; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; ISCHEMIA; LIVER TRANSPLANTATION; MALE; NONHUMAN; RAT; RECIPIENT; REPERFUSION INJURY; SURVIVAL; ALLOTRANSPLANTATION; ANIMAL; DONOR; DRUG ANTAGONISM; GRAFT SURVIVAL; INJURY; LEWIS RAT; LIVER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; ENZYME INHIBITORS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; METHACRYLATES; RATS; RATS, INBRED LEW; REPERFUSION INJURY; TACROLIMUS; THROMBOXANE-A SYNTHASE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1842852067     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.51.76     Document Type: Article

References (21)

1. Soejima Y, Yanaga K, Nisizaki T, Yoshizumi T, Uchiyama H, Sugimachi K: Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation. Surgery 123: 67-72, 1998
2. Suehiro T, Yanaga K, Itasaka H, Kishikawa K, Shirbe K, Shimada M, Sugimachi K: Tnromboxane A2 in preservation-Reperfusion Injury: The Effect of Thromboxane A2 Synthetase Inhibitor. Journal of Surgical Research 62: 216-223, 1996
3. Takada Y, Taniguchi H, Fukunaga K, Yuzawa K, Otsuka M, Todoroki T, Iijima T, Fukao K: Prolonged hepatic warm ischemia in non-heart-beating donors: Protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. Surgery 123: 692-697, 1998
4. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Transplantation 28: 47, 1979
5. David JR, Santiago JM, Kenneth DR, Howard MN, John ME, Richard DH, Cosme YM: Controlled Non-heart-beating Donor Liver Transplantation. Transplantation 70: 1159-1166, 8, 2000
6. Institute of Medicine, National Academy of Sciences: Non-heart-beating organ transplantation: Medical and ethical issues in procurement. National Academy Press, Washington, DC, 1997
7. Oogler T, Costarino AT Jr: The potential benefits of the pediatric non-heart-beating organ donor. Pediatrics 101: 1049, 1998
8. Delva E, Barberousse JP, Nordilinger B, Ollivier JM, Vacher B, Guilmet C, Huguet C: Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 95(3): 309-318, 1984
9. Kawano K, Bowers JL, Clouse ME: Protective effect of FK506 on hepatic injury following cold ischemic preservation and transplantation: Influence on hepatic microcirculation. Transplant Proc 27(1): 362-3, 1995
10. Kawano K, Kim YI, Goto S, Ono M, Kobayashi M: A protective effect of FK506 in ischemically injured rat livers. Transplantation 52(1): 143-145, 1991
11. Kawano K, Kim YI, Ishii T, Tatsuma T, Morimoto A, Tamura Y, Kobayashi M: Evidence that FK 506 alleviates ischemia/reperfusion injury to the rat liver in vivo demonstration for suppression of TNF-α production in response to endotoxemia. Eur Surg Res 26(2): 108-115, 1994
12. Isozaki H, Okajima K, Hara H, Kobayashi M: The Protective Effect of Thromboxane A2 Synthetase Inhibitor Against Ischemic Liver Injury. Surgery Today: 435-440, 1994
13. Ball HA, Cook JA, Wise WC, Hlushka PV: Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med: 116-126, 1986
14. Deby-Dupont G, Braum M, Lamy M, Deby C, Pincemail J, Faymonville ME, Damas P, Bodson L, Lecart MP, Goutier R: Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care Med: 167-174, 1987
15. Margreiter R: European Tacrolimus vs. Cyclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: A randomized multicentre study. The Lancet: 741-746, 2002
16. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wike CA, Strieter RM: The role of cytokine networks in local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology: 506-514, 1996
17. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest: 1936-1943, 1990
18. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J: 3355-3359, 1990
19. Kaibori M, Inoue T, Tu W, Oda M, Kwon A-H, Kamiyama Y, Okumura T: FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Lif Sci: 17-26, 2001
20. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K: Involvement of an NF-kappaB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol: 561-568, 1990
21. Kawano K, Bowers JL, Clouse ME: Protective Effect of FK506 on Hepatic Injury Following Cold Ischemic Preservation and Transplantation: Influence on Hepatic Microcirculation Transplantation Proceedings 27: 362-363, 1995